Sex steroids levels in chronic kidney disease and kidney transplant recipients: Associations with disease severity and prediction of mortality

Clinical Endocrinology

Volumn 82, Issue 5, 2015, Pages 767-775

  Grossmann, Mathis ^a,b   Hoermann, Rudolf ^a   Ng Tang Fui, Mark ^a,b   Zajac, Jeffrey D ^a,b   Ierino, Franscesco L ^a,b   Roberts, Matthew A ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ESTRADIOL; HEMOGLOBIN; SERUM ALBUMIN; SEX HORMONE; TESTOSTERONE; TROPONIN T;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; SURVIVAL; TANDEM MASS SPECTROMETRY; WAIST CIRCUMFERENCE; BLOOD; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGED; BODY MASS INDEX; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEX FACTORS; TANDEM MASS SPECTROMETRY; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84927028353     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12656     Document Type: Article

References (38)

1. Handelsman, D.J., &, Dong, Q., (1993) Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinology and Metabolism Clinics of North America, 22, 145-161.
2. Iglesias, P., Carrero, J.J., &, Diez, J.J., (2012) Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. Journal of Nephrology, 25, 31-42.
3. Carrero, J.J., &, Stenvinkel, P., (2012) The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrology Dialysis Transplantation, 27, 4030-4041.
4. Grossmann, M., (2011) Low testosterone in men with type 2 diabetes: significance and treatment. Journal of Clinical Endocrinology and Metabolism, 96, 2341-2353.
5. Meuwese, C.L., &, Carrero, J.J., (2013) Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg? Archives of Medical Research, 44, 591-600.
6. Dubey, R.K., &, Jackson, E.K., (2001) Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. American Journal of Physiology. Renal Physiology, 280, F365-F388.
7. Haring, R., Nauck, M., Volzke, H., et al,. (2011) Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy. American Journal of Nephrology, 33, 209-217.
8. Gungor, O., Kircelli, F., Carrero, J.J., et al,. (2010) Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging? Clinical Journal of the American Society of Nephrology: CJASN, 5, 2018-2023.
9. Bello, A.K., Stenvinkel, P., Lin, M., et al,. (2014) Serum testosterone levels and clinical outcomes in male hemodialysis patients. American Journal of Kidney Diseases, 63, 268-275.
10. Carrero, J.J., Qureshi, A.R., Parini, P., et al,. (2009) Low serum testosterone increases mortality risk among male dialysis patients. Journal of the American Society of Nephrology, 20, 613-620.
11. Yi, S., Selvin, E., Rohrmann, S., et al,. (2009) Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. Clinical Endocrinology (Oxford), 71, 246-252.
12. Khurana, K.K., Navaneethan, S.D., Arrigain, S., et al,. (2014) Serum testosterone levels and mortality in men with CKD stages 3-4. American Journal of Kidney Diseases, 64, 367-374.
13. Grossmann, M., Thomas, M.C., Panagiotopoulos, S., et al,. (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. Journal of Clinical Endocrinology and Metabolism, 93, 1834-1840.
14. Swerdloff, R.S., Wang, C., Cunningham, G., et al,. (2000) Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 85, 4500-4510.
15. Travison, T.G., Shackelton, R., Araujo, A.B., et al,. (2008) The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission. Journal of the American Geriatrics Society, 56, 831-839.
16. Rosner, W., Auchus, R.J., Azziz, R., et al,. (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism, 92, 405-413.
17. Roberts, M.A., MacMillan, N., Hare, D.L., et al,. (2006) Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list. Nephrology (Carlton), 11, 471-476.
18. Roberts, M.A., Srivastava, P.M., Macmillan, N., et al,. (2008) B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis. Clinical Journal of the American Society of Nephrology: CJASN, 3, 1057-1065.
19. Roberts, M.A., Hare, D.L., Macmillan, N., et al,. (2009) Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis. Annals of Clinical Biochemistry, 46, 291-295.
20. Harwood, D.T., &, Handelsman, D.J., (2009) Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clinica Chimica Acta, 409, 78-84.
21. Grossmann, M., Hoermann, R., Gani, L., et al,. (2012) Low testosterone levels as an independent predictor of mortality in men with chronic liver disease. Clinical Endocrinology (Oxford), 77, 323-328.
22. R Core Team. (2014) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: http://wwwR-projectorg/ (accessed 15 May 2014).
23. Bates, D., Maechler, M., &, Bolker, M., (2013) lme4: Linear Mixed-Effects Models Using S4 Classes. R package version 0.999999-2. Available from: http://CRAN.R-project.org/package=lme4 (accessed 20 May 2014).
24. Bhasin, S., Cunningham, G.R., Hayes, F.J., et al,. (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 95, 2536-2559.
25. Brambilla, D.J., O'Donnell, A.B., Matsumoto, A.M., et al,. (2007) Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clinical Endocrinology (Oxford), 67, 853-862.
26. Sikaris, K., McLachlan, R.I., Kazlauskas, R., et al,. (2005) Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. Journal of Clinical Endocrinology and Metabolism, 90, 5928-5936.
27. Grossmann, M., (2014) Testosterone and glucose metabolism in men: current concepts and controversies. Journal of Endocrinology, 220, R37-R55.
28. Lapi, F., Azoulay, L., Niazi, M.T., et al,. (2013) Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer. JAMA, 310, 289-296.
29. Araujo, A.B., Dixon, J.M., Suarez, E.A., et al,. (2011) Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism, 96, 3007-3019.
30. Saha, M.T., Saha, H.H., Niskanen, L.K., et al,. (2002) Time course of serum prolactin and sex hormones following successful renal transplantation. Nephron, 92, 735-737.
31. van Coevorden, A., Stolear, J.C., Dhaene, M., et al,. (1986) Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients. Clinical Nephrology, 26, 48-54.
32. Hendler, E.D., Goffinet, J.A., Ross, S., et al,. (1974) Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. New England Journal of Medicine, 291, 1046-1051.
33. Johansen, K.L., Mulligan, K., &, Schambelan, M., (1999) Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA, 281, 1275-1281.
34. Finkle, W.D., Greenland, S., Ridgeway, G.K., et al,. (2014) Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One, 9, e85805.
35. Kakiya, R., Shoji, T., Hayashi, T., et al,. (2012) Decreased serum adrenal androgen dehydroepiandrosterone sulfate and mortality in hemodialysis patients. Nephrology, Dialysis, Transplantation, 27, 3915-3922.
36. Hsu, H.J., Yen, C.H., Chen, C.K., et al,. (2012) Low plasma DHEA-S increases mortality risk among male hemodialysis patients. Experimental Gerontology, 47, 950-957.
37. Corona, G., Rastrelli, G., Giagulli, V.A., et al,. (2013) Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. Journal of Clinical Endocrinology and Metabolism, 98, 3615-3626.
38. Yeap, B.B., Alfonso, H., Chubb, S.A., et al,. (2014) In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while oestradiol levels do not predict mortality. Journal of Clinical Endocrinology and Metabolism, 99, E9-E18.